Skip to Main Content

Paper Details

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.
Nat Commun
6
2022
Author NameAffiliation
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Brian M FeldmanPerelman School of Medicine at the University of Pennsylvania
Brian M FeldmanAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Susan M DomchekBasser Center for BRCA, Perelman School of Medicine at the University of Pennsylvania
Susan M DomchekPerelman School of Medicine at the University of Pennsylvania
Katherine L NathansonPerelman School of Medicine at the University of Pennsylvania
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Katherine L NathansonBasser Center for BRCA, Perelman School of Medicine at the University of Pennsylvania
  • 1 - 10

Datasets

Release 1.2